Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
ALCOBRA LTD. (ARCT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/15/2018 6-K Quarterly results
10/01/2018 6-K Quarterly results
09/28/2018 6-K Quarterly results
08/29/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2018 Commission File No. 001-35932 ARCTURUS THERAPEUTICS LTD. 10628 Science Center Drive, Suite 250 San Diego, California 92121 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Other Events Arcturus Therapeutics Ltd. held an annual and extraordinary g...",
"Letter of Kost, Forer, Gabbay & Kasierer to the Securities and Exchange Commission",
"Arcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company’ s Independent Auditor",
"Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer"
07/27/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2018 Commission File No. 001-35932 ARCTURUS THERAPEUTICS LTD. 10628 Science Center Drive, Suite 250 San Diego, California 92121 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Other Events On July 20, 2018, Arcturus Therapeutics Ltd. published a notice...",
"Notice and Proxy Statement for the Annual and Extraordinary General Meeting of Shareholders to be held on Friday, August 24, 2018 (“Proxy Statement”)",
"Appendix A to the Proxy Statement: Amended and Restated Compensation Policy for Company Office Holders",
"Appendix B to the Proxy Statement: Company 2018 Omnibus Equity Incentive Plan",
"Form of Proxy Card"
07/20/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2018 Commission File No. 001-35932 ARCTURUS THERAPEUTICS LTD. 10628 Science Center Drive, Suite 250 San Diego, California 92121 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Other Events On July 20, 2018, Arcturus Therapeutics Ltd. published a notice...",
"ARCTURUS THERAPEUTICS LTD. 10628 Science Center Drive, Suite 250, San Diego, CA 92121 Tel: 900-2666 ARCTURUS THERAPEUTICS ANNOUNCES annual and EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 24, 2018"
07/10/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2018 Commission File No. 001-35932 ARCTURUS THERAPEUTICS LTD. 10628 Science Center Drive, Suite 250 San Diego, California 92121 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Other Events On July 9, 2018, Arcturus Therapeutics Ltd. published a press r...",
"Arcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders"
06/15/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2018 Commission File No. 001-35932 ARCTURUS THERAPEUTICS LTD. 10628 Science Center Drive, Suite 250 San Diego, California 92121 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: o Other Events Extraordinary General Meeting of Shareholders On June 15, 2018,...",
"Invitation and Proxy Statement for the Arcturus Therapeutics Ltd. Extraordinary General Meeting of shareholders",
"Form of Proxy Card for the Extraordinary General Meeting"
05/29/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Agreement and Release of Arcturus Therapeutics Ltd",
"Agreement and Release of Arcturus Therapeutics Ltd",
"Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne"
05/24/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Order Granting in Part and Denying in Part Plaintiff's Motion for Preliminary Injunction and Expedited Discovery",
"Order Granting in Part and Denying in Part Plaintiff's Motion for Preliminary Injunction and Expedited Discovery"
05/21/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"ARCTURUS THERAPEUTICS Announces EXTRAORDINARY General Meeting of Shareholders"
05/14/2018 6-K Quarterly results
04/09/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Arcturus Therapeutics Issues Statement Regarding Timing of Extraordinary General Meeting of Shareholders"
04/02/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Letter to Company Employees from Mark Herbert",
"Letter to Company Employees from Mark Herbert"
02/13/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/05/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cover Letter and Proxy Statement, each dated February 5, 2018, being sent by the Company to its shareholders in connection with the Meeting",
"Proxy Card being sent by the Company to its shareholders for use in connection with the Meeting"
02/02/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
01/24/2018 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
11/16/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Commences Trading on the Nasdaq Global Market"
11/13/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
11/09/2017 6-K Quarterly results
Docs: "FORM 6-K",
"ALCOBRA ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
11/07/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
10/20/2017 6-K Quarterly results
10/20/2017 6-K Quarterly results
09/28/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge",
"Agreement and Plan of Merger and Reorganization, among Alcobra Ltd., Aleph MergerSub, Inc. and Arcturus Therapeutics, Inc",
"Corporate presentation"
09/14/2017 6-K Quarterly results
08/11/2017 6-K Quarterly results
06/23/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/12/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/30/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/15/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/05/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/27/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/24/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy